Last €23.12 EUR
Change Today 0.00 / 0.00%
Volume 0.0
PHIA On Other Exchanges
Symbol
Exchange
New York
EN Amsterdam
OTC US
Xetra
BrsaItaliana
EN Amsterdam
As of 11:35 AM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).

koninklijke philips nv (PHIA) Snapshot

Open
€23.17
Previous Close
€23.12
Day High
€23.23
Day Low
€23.03
52 Week High
01/20/14 - €28.31
52 Week Low
08/8/14 - €21.89
Market Cap
22.1B
Average Volume 10 Days
1.9M
EPS TTM
€1.15
Shares Outstanding
956.7M
EX-Date
05/5/14
P/E TM
20.1x
Dividend
€0.80
Dividend Yield
3.46%
Current Stock Chart for KONINKLIJKE PHILIPS NV (PHIA)

Related News

No related news articles were found.

koninklijke philips nv (PHIA) Details

Koninklijke Philips N.V. is engaged in healthcare, consumer lifestyle, and lighting businesses worldwide. Its healthcare solutions include radiation oncology, clinical applications and platforms, and portfolio management; advanced diagnostic imaging, such as computed tomography (CT), magnetic resonance imaging (MRI), and molecular imaging; digital X-ray and mammography; interventional X-rays; ultrasound products; enterprise patient monitoring solutions for clinical information at the patient’s bedside; cardiology informatics and enterprise imaging informatics; patient monitoring and clinical informatics; mother and child care products; therapeutic care products; sleep management, respiratory care, and non-invasive ventilation; medical alert and medication dispensing services; remote patient monitoring; and equipment services and support, equipment financing and asset management, and professional services. The company's consumer lifestyle solutions consist of mother and childcare, oral healthcare, pain management, male grooming, and beauty products; and kitchen appliances, coffee, garment care, floor care, and air purification products. Its lighting solutions include light sources and electronics, such as LED, eco-halogen, fluorescent, discharge, and incandescent light sources, as well as electronic and electromagnetic gears, modules, and drivers; consumer luminaires, including functional, decorative, lifestyle, and scene-setting luminaires; professional lighting solutions, such as controls and luminaires for city beautification, road lighting, sports lighting, office lighting, shop/hospitality lighting, and industry lighting; automotive lighting products; and packaged LEDs. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

99,769 Employees
Last Reported Date: 07/21/14
Founded in 1891

koninklijke philips nv (PHIA) Top Compensated Officers

Chief Executive Officer, Chairman of the Boar...
Total Annual Compensation: €2.2M
Chief Financial Officer, Executive Vice-Presi...
Total Annual Compensation: €1.2M
Executive Vice-President, Chief Executive Off...
Total Annual Compensation: €1.2M
Compensation as of Fiscal Year 2013.

koninklijke philips nv (PHIA) Key Developments

Royal Philips Announces New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014

Royal Philips announced its presence at the European Society of Cardiology (ESC) Congress 2014, where the company is highlighting the full range of its cardiology solutions serving clinicians and patients across the care continuum from prevention and diagnosis, to treatment, recovery and wellness. Visitors to the Philips booth will experience Philips' new Cardiology Solutions approach, enabling clinicians and health systems to deliver better cardiovascular care for more patients, at lower a cost, in the treatment of coronary artery disease, structural heart disease, and heart failure. Philips Cardiology Solutions meet the needs of clinicians who are at the center of the cardiovascular care. Philips' breadth of diagnostic and treatment solutions offer real-time tools to connect patient information with clinician knowledge, resulting in more personalized care, while innovations for recovery and wellness provide a safer transition from hospital to home. On August 30, Philips' newest ultrasound system will make its worldwide debut, with an unveiling at the Philips Booth (#F500) at 4 p.m. CET. Beginning August 30th and running through September 3rd at the ESC Congress 2014, Philips will also offer demonstrations of its advanced imaging and ultrasound solutions designed for every step of the patient journey, including: ST80i ECG Stress Testing System; Philips IntelliSpace ECG; Xcelera Image Management System; IntelliSpace Portal with TAVI package; EPIQ Ultrasound; Allura Clarity with ClarityIQ; EchoNavigator R2 with Image Fusion; Hybrid OR; Heart Navigator; Q-Station, with anatomical intelligence tools and Motiva mobile.

Royal Philips Receives 510(K) Clearance to Market Precision Planning Application for Transcatheter Aortic-Valve Implantation (TAVI) Treatments

Royal Philips announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market its precision planning application for Transcatheter Aortic-Valve Implantation (TAVI) treatments. Through 3D imaging, the Philips TAVI application provides interventionalists with pre-procedural, high-precision positioning to treat aortic stenosis ailments. The Philips TAVI planning application is available as part of Philips IntelliSpace Portal 6 -- the company's advanced visualization and analysis solution that allows clinicians to access and analyze patient imaging and data virtually anywhere, at any time. The application features a comprehensive measurement package to accommodate virtually all types of TAVI devices. Through advanced computed tomography imaging, the TAVI planning application provides planes and panel measurements for precisely placing TAVI devices to manage the risk of under- or oversizing of a TAVI device. It renders images into a 3D heart model to allow interventionalists to orient the device and address less-than-optimal patient cases.

Royal Philips and Accenture Develop Proof of Concept Software Connecting Wearable Display to Emotiv Insight Brainware

Royal Philips and Accenture announced that they have developed proof of concept software connecting a wearable display to Emotiv Insight Brainware that could ultimately give more independence to patients with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. When a wearable display and the Emotiv Insight Brainware, which scans EEG brainwaves, are connected to a tablet, users can issue brain commands to control Philips products including Philips Lifeline Medical Alert Service, Philips SmartTV (with TP Vision), and Philips Hue personal wireless lighting. The tablet also allows control of these products using eye and voice commands. In both cases, a person could communicate preconfigured messages, request medical assistance, and control TVs and lights. Accenture and Philips developed the software that enables the integration and interaction between these multiple technologies. The proof of concept application demonstrates how existing technology could be used to transform the quality of life for ALS patients. When patients lose muscle control and eye tracking ability, they can still potentially operate the Philips suite of connected products in their home environment through brain commands. The Emotiv technology uses sensors to tune in to electric signals produced by the wearer's brain to detect, in real-time, their thoughts, feelings and expressions. The wearable display provides visual feedback that allows the wearer to navigate through the application menu.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHIA:NA €23.12 EUR 0.00

PHIA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bridgestone Corp ¥3,625 JPY -7.00
Canon Inc ¥3,447 JPY +27.00
FUJIFILM Holdings Corp ¥3,232 JPY +33.50
Linde AG €150.66 EUR +0.45
Mitsubishi Electric Corp ¥1,361 JPY +5.50
View Industry Companies
 

Industry Analysis

PHIA

Industry Average

Valuation PHIA Industry Range
Price/Earnings 19.5x
Price/Sales 0.9x
Price/Book 1.9x
Price/Cash Flow 19.9x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KONINKLIJKE PHILIPS NV, please visit www.philips.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.